Thus, a better understanding of the underlying mechanism of CART increase in DMH in hypertension would help to uncover new pharmacological and potentially nonpharmacological therapies to overcome the common maladies caused by hypertension secondary to obesity. The gene discussed is CARTPT; the disease is obesity disorder.